BIRC3 and AIDS dementia complex: To this regard, a multicenter, randomized phase II study on BIRC3-expression driven therapy (nCRT versus upfront surgery), in patients with resectable ADC of the esophagus and EGJ, is currently ongoing (BoRgES trial, NCT04269083) at the authors’ institution.